RAPT Therapeutics, Inc. (RAPT) Return on Assets (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Return on Assets for 5 consecutive years, with 0.97% as the latest value for Q3 2024.
- Quarterly Return on Assets fell 41.0% to 0.97% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.97% through Sep 2024, down 41.0% year-over-year, with the annual reading at 0.58% for FY2023, 21.0% down from the prior year.
- Return on Assets hit 0.97% in Q3 2024 for RAPT Therapeutics, down from 0.91% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.29% in Q3 2021 to a low of 0.97% in Q3 2024.
- Historically, Return on Assets has averaged 0.5% across 5 years, with a median of 0.4% in 2020.
- Biggest five-year swings in Return on Assets: grew 13bps in 2022 and later plummeted -46bps in 2024.
- Year by year, Return on Assets stood at 0.43% in 2020, then increased by 25bps to 0.32% in 2021, then decreased by -13bps to 0.36% in 2022, then plummeted by -89bps to 0.68% in 2023, then tumbled by -43bps to 0.97% in 2024.
- Business Quant data shows Return on Assets for RAPT at 0.97% in Q3 2024, 0.91% in Q2 2024, and 0.78% in Q1 2024.